COMPOUND WITH CONFIDENCE: PCCA Membership, $895/month.
Our blog search feature is temporarily unavailable while we work to resolve an issue. We apologize for the inconvenience and appreciate your patience. We’ll restore it as soon as possible.
Stay current on PCCA news and events, market trends, and all things compounding!
Nat Jones of PCCA's Clinical Services Team discusses the clinical data about the efficacy of Permeation-enhanced topical pain therapy (PETPT) or transdermal pain therapy. He provides a brief history of transdermal pain therapy and evidence of the levels of efficacy PETPT has within medicine.
We're working to improve website accessibility. Need help? Call 800.331.2498 or view our Accessibility Notice.